书签 分享 收藏 举报 版权申诉 / 5
1

类型[20190125]LSB10225_“秘密销售”是否触发了《美国发明法案》规定的销售专利限制?.pdf

  • 上传人:任**
  • 文档编号:27857
  • 上传时间:2022-06-24
  • 发布时间:2019-03-20
  • 格式:PDF
  • 页数:5
  • 大小:727.02KB
  • CRS Legal Sidebar Prepared for Members and Committees of Congress Legal SidebarLegal Sidebari i Do “Secret Sales” Trigger the On-Sale Bar to Patentability under the America Invents Act? Updated January 25, 2019 UPDATE (January 25, 2019): On January 22, 2019, the Supreme Court issued its opinion in Helsinn Healthcare S.A. v. Teva Pharmaceuticals Inc. Justice Thomass opinion for a unanimous Court held that a commercial sale of an invention to a third party who is required to keep an invention confidential places an invention “on sale” within the meaning of the Patent Act. The Court reaffirmed its holding in Pfaff v. Wells Electronics, Inc. that a patentable invention is considered “on sale” if it is (1) “the subject of a commercial offer for sale”; and (2) “ready for patenting.” More specifically, the Court concluded that the 2011 America Invents Acts addition of a new catchall category of prior art that is “otherwise available to the public” did not alter the “well-settled meaning” of the on-sale bar, which requires an inventor to apply for a patent within one year after an invention is on sale. The original post on Helsinn v. Teva, from December 3, 2018, is reproduced below. In gen
    展开阅读全文
    特殊限制:

    部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。

    关 键  词:
    20190125 美国发明法案 LSB10225_ 秘密 销售 是否 触发 美国 发明 法案 规定 专利 限制
    1
    提示  联参智库所有资源均是用户自行上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作他用。
    关于本文
    本文标题:[20190125]LSB10225_“秘密销售”是否触发了《美国发明法案》规定的销售专利限制?.pdf
    链接地址:https://www.lianhezuozhan.com/doc/27857.html
    1

    客服:010-66465788   北京联参科技有限公司版权所有  工业和信息化部备案/许可证编号:京ICP备2022007273号-1



    联参智库